July 2017

Chairman's Letter
Chairman’s Letter
Michael J. Hennessy, Sr
From the Editor
From the Editor
Debu Tripathy, MD
Colorectal Cancer
Advances in Immunotherapy in the Treatment of Colorectal Cancer
Birendra KC, MD; Jimmy J Hwang, MD; Carol J Farhangfar, PhD, MBA; and S. Jean Chai, MD
HER2-Positive Breast Cancer
Raising the Therapeutic Index for HER2-Targeted Therapy: Can We Safely Omit Anthracyclines in the Adjuvant Setting?
Kelly E. McCann, MD, PhD, and Sara A. Hurvitz, MD
Lung Cancer
Frontline Immunotherapy in Non–Small Cell Lung Cancer: For Which Patients Is Platinum Passé?
Jeffrey Zweig, MD, and Sukhmani K. Padda, MD
Breast Cancer
Knowledge, Practices, and Attitudes of Women Toward Breast Cancer in Lebanon
Myrna A.A. Doumit, PhD, MPH, BSN; Suha Fares, PhD; and Mary Arevian, MPH, BSN
Oncology Briefings™: Overcoming Chronic Iron Overload in Pediatric AML and MDS
Elias Jabbour, MD, Latika Puri, MD
Checkpoint Inhibitors: Where Have We Been and Where Are We Going in Advanced Non–Small Cell Lung Cancer?